Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proto-Oncogene Proteins p21(ras) | 24 | 2024 | 1745 | 3.970 |
Why?
|
Genes, ras | 19 | 2023 | 654 | 2.880 |
Why?
|
ras Proteins | 18 | 2023 | 1054 | 2.330 |
Why?
|
Colitis | 6 | 2019 | 1233 | 1.310 |
Why?
|
Intestinal Mucosa | 14 | 2024 | 3032 | 1.310 |
Why?
|
Oncogenes | 4 | 2022 | 1222 | 1.300 |
Why?
|
Mutation | 30 | 2024 | 30052 | 1.060 |
Why?
|
Gene Regulatory Networks | 5 | 2021 | 1745 | 1.020 |
Why?
|
GTP Phosphohydrolases | 7 | 2022 | 517 | 0.990 |
Why?
|
Cell Transformation, Neoplastic | 10 | 2023 | 2825 | 0.980 |
Why?
|
Tumor Necrosis Factor-alpha | 7 | 2015 | 4352 | 0.920 |
Why?
|
Colorectal Neoplasms | 15 | 2024 | 6935 | 0.870 |
Why?
|
Intestinal Neoplasms | 8 | 2024 | 312 | 0.850 |
Why?
|
Organ Specificity | 4 | 2021 | 1967 | 0.800 |
Why?
|
Apoptosis | 13 | 2015 | 9486 | 0.740 |
Why?
|
Lentivirus | 2 | 2014 | 508 | 0.740 |
Why?
|
Alleles | 5 | 2021 | 6863 | 0.720 |
Why?
|
Lysine | 2 | 2023 | 993 | 0.710 |
Why?
|
Animals, Genetically Modified | 3 | 2019 | 1561 | 0.670 |
Why?
|
Intracellular Signaling Peptides and Proteins | 5 | 2021 | 2872 | 0.670 |
Why?
|
MAP Kinase Signaling System | 6 | 2014 | 1486 | 0.670 |
Why?
|
Pancreatic Neoplasms | 5 | 2024 | 5368 | 0.670 |
Why?
|
MicroRNAs | 4 | 2023 | 3816 | 0.660 |
Why?
|
Neoplasms | 12 | 2023 | 22170 | 0.660 |
Why?
|
Colonic Neoplasms | 8 | 2014 | 2538 | 0.630 |
Why?
|
Proto-Oncogene Proteins | 9 | 2017 | 4511 | 0.620 |
Why?
|
Proteomics | 8 | 2023 | 3849 | 0.610 |
Why?
|
Signal Transduction | 20 | 2022 | 23445 | 0.600 |
Why?
|
Adenomatous Polyposis Coli Protein | 9 | 2019 | 181 | 0.580 |
Why?
|
Rectal Neoplasms | 4 | 2014 | 1157 | 0.570 |
Why?
|
p21-Activated Kinases | 1 | 2018 | 128 | 0.570 |
Why?
|
Genes, Neoplasm | 1 | 2019 | 370 | 0.560 |
Why?
|
Mice | 60 | 2024 | 81525 | 0.560 |
Why?
|
Carcinoma, Pancreatic Ductal | 4 | 2022 | 1727 | 0.540 |
Why?
|
Colon | 6 | 2019 | 1792 | 0.530 |
Why?
|
Animals | 68 | 2024 | 168459 | 0.520 |
Why?
|
Metabolic Networks and Pathways | 2 | 2020 | 789 | 0.520 |
Why?
|
Intestines | 3 | 2024 | 1909 | 0.510 |
Why?
|
Genes, Tumor Suppressor | 4 | 2021 | 1062 | 0.500 |
Why?
|
Integrases | 2 | 2014 | 516 | 0.480 |
Why?
|
Galactosides | 1 | 2014 | 54 | 0.470 |
Why?
|
Genetic Vectors | 2 | 2014 | 3395 | 0.460 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2023 | 2898 | 0.460 |
Why?
|
Homeostasis | 7 | 2024 | 3323 | 0.460 |
Why?
|
Siblings | 1 | 2018 | 825 | 0.440 |
Why?
|
Cytokines | 4 | 2018 | 7396 | 0.430 |
Why?
|
Cell Proliferation | 11 | 2024 | 10445 | 0.430 |
Why?
|
Sirtuin 2 | 1 | 2013 | 95 | 0.420 |
Why?
|
beta-Galactosidase | 1 | 2014 | 574 | 0.420 |
Why?
|
Protein Processing, Post-Translational | 5 | 2013 | 1974 | 0.410 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2022 | 8547 | 0.400 |
Why?
|
Precancerous Conditions | 2 | 2011 | 980 | 0.400 |
Why?
|
Nucleotides | 3 | 2024 | 454 | 0.400 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2013 | 350 | 0.390 |
Why?
|
Epithelial Cells | 7 | 2015 | 3673 | 0.380 |
Why?
|
Retinoblastoma Protein | 5 | 2015 | 672 | 0.360 |
Why?
|
Gene Expression Profiling | 6 | 2019 | 9420 | 0.360 |
Why?
|
Genes, Reporter | 2 | 2014 | 1529 | 0.360 |
Why?
|
Guanine Nucleotide Exchange Factors | 4 | 2023 | 569 | 0.360 |
Why?
|
Proto-Oncogene Proteins B-raf | 9 | 2014 | 2057 | 0.350 |
Why?
|
Niacinamide | 1 | 2012 | 413 | 0.350 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 3802 | 0.340 |
Why?
|
Adenoviridae | 1 | 2014 | 1084 | 0.340 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2015 | 2455 | 0.340 |
Why?
|
Staining and Labeling | 1 | 2014 | 1085 | 0.340 |
Why?
|
Models, Biological | 7 | 2015 | 9469 | 0.330 |
Why?
|
Structure-Activity Relationship | 5 | 2020 | 3076 | 0.330 |
Why?
|
Inflammation Mediators | 2 | 2015 | 1886 | 0.320 |
Why?
|
Pyrimidines | 3 | 2021 | 3028 | 0.320 |
Why?
|
Histone Deacetylases | 1 | 2013 | 719 | 0.310 |
Why?
|
Mice, Inbred C57BL | 21 | 2024 | 22169 | 0.300 |
Why?
|
Guanosine Triphosphate | 2 | 2022 | 316 | 0.280 |
Why?
|
Indoles | 2 | 2014 | 1833 | 0.270 |
Why?
|
Monomeric GTP-Binding Proteins | 2 | 2020 | 200 | 0.270 |
Why?
|
Cell Line, Tumor | 16 | 2021 | 16981 | 0.260 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2011 | 1246 | 0.260 |
Why?
|
Lung Neoplasms | 4 | 2024 | 13380 | 0.260 |
Why?
|
Retinoblastoma-Like Protein p130 | 1 | 2005 | 73 | 0.260 |
Why?
|
Retinoblastoma-Like Protein p107 | 1 | 2005 | 71 | 0.260 |
Why?
|
Lipoylation | 2 | 2020 | 87 | 0.260 |
Why?
|
Enzyme Inhibitors | 2 | 2013 | 3712 | 0.260 |
Why?
|
Principal Component Analysis | 2 | 2019 | 943 | 0.260 |
Why?
|
Disease Models, Animal | 12 | 2021 | 18252 | 0.250 |
Why?
|
Sirtuins | 2 | 2024 | 320 | 0.240 |
Why?
|
Protein Kinase Inhibitors | 4 | 2020 | 5671 | 0.240 |
Why?
|
Cell Differentiation | 7 | 2024 | 11528 | 0.240 |
Why?
|
Lymphocytes | 1 | 2012 | 2612 | 0.240 |
Why?
|
Loss of Heterozygosity | 3 | 2007 | 662 | 0.230 |
Why?
|
Gene Expression Regulation | 8 | 2020 | 11903 | 0.230 |
Why?
|
Rome | 1 | 2023 | 28 | 0.230 |
Why?
|
Recombination, Genetic | 2 | 2014 | 1519 | 0.230 |
Why?
|
Mice, Transgenic | 10 | 2021 | 9539 | 0.230 |
Why?
|
Stem Cells | 3 | 2015 | 3522 | 0.220 |
Why?
|
Least-Squares Analysis | 2 | 2015 | 369 | 0.210 |
Why?
|
Carcinoma | 2 | 2011 | 2330 | 0.210 |
Why?
|
Adenoma | 5 | 2012 | 2160 | 0.200 |
Why?
|
Allosteric Regulation | 1 | 2023 | 426 | 0.200 |
Why?
|
Humans | 60 | 2024 | 761504 | 0.200 |
Why?
|
MAP Kinase Kinase Kinases | 3 | 2014 | 255 | 0.190 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2021 | 56 | 0.190 |
Why?
|
Acetonitriles | 1 | 2021 | 54 | 0.190 |
Why?
|
Genes, APC | 3 | 2009 | 145 | 0.190 |
Why?
|
Cells, Cultured | 8 | 2021 | 18965 | 0.180 |
Why?
|
Angiogenic Proteins | 1 | 2021 | 101 | 0.180 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2020 | 113 | 0.170 |
Why?
|
Acetylation | 2 | 2013 | 1055 | 0.170 |
Why?
|
Phenotype | 9 | 2021 | 16591 | 0.170 |
Why?
|
Microsatellite Repeats | 1 | 2002 | 784 | 0.170 |
Why?
|
Phosphorylation | 3 | 2020 | 8320 | 0.170 |
Why?
|
Epithelium | 2 | 2018 | 1603 | 0.160 |
Why?
|
Neovascularization, Pathologic | 2 | 2021 | 2645 | 0.160 |
Why?
|
Cluster Analysis | 2 | 2019 | 2707 | 0.160 |
Why?
|
Genotype | 6 | 2017 | 12990 | 0.160 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 615 | 0.160 |
Why?
|
Cell Survival | 5 | 2015 | 5791 | 0.150 |
Why?
|
Immune Evasion | 1 | 2021 | 363 | 0.150 |
Why?
|
Mice, Knockout | 12 | 2021 | 14414 | 0.150 |
Why?
|
Chemokine CCL2 | 3 | 2021 | 605 | 0.150 |
Why?
|
Phosphatidylinositol 3-Kinases | 6 | 2014 | 2865 | 0.150 |
Why?
|
Protein Conformation | 3 | 2021 | 3968 | 0.140 |
Why?
|
Crystallography, X-Ray | 1 | 2022 | 1990 | 0.140 |
Why?
|
Translocation, Genetic | 1 | 2002 | 1393 | 0.140 |
Why?
|
Pancreas | 1 | 2024 | 1691 | 0.140 |
Why?
|
Hematopoiesis | 2 | 2020 | 2049 | 0.140 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 687 | 0.140 |
Why?
|
Mammals | 1 | 2022 | 1132 | 0.130 |
Why?
|
Dimerization | 1 | 2018 | 891 | 0.130 |
Why?
|
Neoplasms, Experimental | 1 | 2021 | 1229 | 0.130 |
Why?
|
Neurons | 1 | 2015 | 9463 | 0.130 |
Why?
|
Mass Spectrometry | 2 | 2021 | 2192 | 0.130 |
Why?
|
Adenocarcinoma | 4 | 2016 | 6346 | 0.130 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2016 | 120 | 0.130 |
Why?
|
Cell Cycle | 3 | 2015 | 2932 | 0.130 |
Why?
|
SOS1 Protein | 1 | 2015 | 40 | 0.120 |
Why?
|
Molecular Targeted Therapy | 3 | 2017 | 2811 | 0.120 |
Why?
|
Interleukin-5 | 1 | 2015 | 269 | 0.120 |
Why?
|
Gene Silencing | 1 | 2021 | 1509 | 0.120 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2020 | 718 | 0.120 |
Why?
|
Helicobacter Infections | 2 | 2009 | 388 | 0.120 |
Why?
|
Doxycycline | 1 | 2017 | 344 | 0.120 |
Why?
|
Alzheimer Disease | 2 | 2015 | 8599 | 0.120 |
Why?
|
Catalytic Domain | 2 | 2019 | 705 | 0.120 |
Why?
|
Intestine, Small | 2 | 2012 | 1206 | 0.120 |
Why?
|
Codon | 2 | 2014 | 601 | 0.120 |
Why?
|
CpG Islands | 4 | 2014 | 1230 | 0.120 |
Why?
|
Multivariate Analysis | 3 | 2018 | 12059 | 0.120 |
Why?
|
Systems Biology | 1 | 2018 | 481 | 0.120 |
Why?
|
Dextran Sulfate | 1 | 2015 | 256 | 0.120 |
Why?
|
Antineoplastic Agents | 3 | 2024 | 13639 | 0.110 |
Why?
|
Trans-Activators | 1 | 2023 | 2856 | 0.110 |
Why?
|
Gene Frequency | 1 | 2021 | 3606 | 0.110 |
Why?
|
Fuzzy Logic | 1 | 2013 | 57 | 0.110 |
Why?
|
beta Catenin | 4 | 2019 | 1040 | 0.110 |
Why?
|
Protein Isoforms | 2 | 2019 | 1699 | 0.110 |
Why?
|
Neoplasm Proteins | 3 | 2018 | 3617 | 0.110 |
Why?
|
Oxidative Phosphorylation | 1 | 2015 | 496 | 0.110 |
Why?
|
Hematopoietic System | 1 | 2013 | 110 | 0.110 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2013 | 96 | 0.110 |
Why?
|
Embryonic Stem Cells | 1 | 2020 | 1263 | 0.100 |
Why?
|
Tumor Microenvironment | 3 | 2021 | 3877 | 0.100 |
Why?
|
Helicobacter hepaticus | 2 | 2009 | 25 | 0.100 |
Why?
|
Proteome | 2 | 2021 | 1862 | 0.100 |
Why?
|
Prenylation | 1 | 2012 | 37 | 0.100 |
Why?
|
Pyridones | 1 | 2018 | 809 | 0.100 |
Why?
|
Epididymis | 1 | 2014 | 228 | 0.100 |
Why?
|
Terminology as Topic | 1 | 2019 | 1530 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2012 | 205 | 0.100 |
Why?
|
Administration, Intranasal | 1 | 2014 | 477 | 0.100 |
Why?
|
Hair Color | 1 | 2012 | 131 | 0.100 |
Why?
|
Models, Molecular | 2 | 2019 | 5439 | 0.100 |
Why?
|
Palmitoyl-CoA Hydrolase | 1 | 2011 | 17 | 0.100 |
Why?
|
Protein Biosynthesis | 1 | 2019 | 2113 | 0.100 |
Why?
|
raf Kinases | 1 | 2012 | 118 | 0.100 |
Why?
|
Green Fluorescent Proteins | 2 | 2015 | 2065 | 0.100 |
Why?
|
Administration, Oral | 1 | 2019 | 4021 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 1 | 2020 | 3734 | 0.100 |
Why?
|
Genes, p53 | 2 | 2011 | 712 | 0.100 |
Why?
|
NIH 3T3 Cells | 1 | 2013 | 670 | 0.100 |
Why?
|
Diphenylamine | 1 | 2011 | 49 | 0.090 |
Why?
|
Disease Progression | 4 | 2021 | 13506 | 0.090 |
Why?
|
Transforming Growth Factor beta | 2 | 2017 | 1961 | 0.090 |
Why?
|
HeLa Cells | 2 | 2019 | 3093 | 0.090 |
Why?
|
Quantitative Structure-Activity Relationship | 1 | 2010 | 28 | 0.090 |
Why?
|
Discriminant Analysis | 1 | 2011 | 222 | 0.090 |
Why?
|
Amyloid beta-Peptides | 2 | 2015 | 3839 | 0.090 |
Why?
|
Sirolimus | 1 | 2018 | 1533 | 0.090 |
Why?
|
Cell Communication | 1 | 2018 | 1657 | 0.090 |
Why?
|
Fibroblasts | 1 | 2021 | 4141 | 0.090 |
Why?
|
Piperazines | 1 | 2021 | 2523 | 0.090 |
Why?
|
Neutralization Tests | 1 | 2012 | 728 | 0.090 |
Why?
|
Genes, erbB-2 | 1 | 2011 | 162 | 0.090 |
Why?
|
Skin Pigmentation | 1 | 2012 | 277 | 0.090 |
Why?
|
COS Cells | 1 | 2012 | 1130 | 0.090 |
Why?
|
Kinetics | 1 | 2018 | 6374 | 0.090 |
Why?
|
HCT116 Cells | 3 | 2019 | 404 | 0.090 |
Why?
|
Hematologic Neoplasms | 2 | 2020 | 1896 | 0.090 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2011 | 256 | 0.090 |
Why?
|
Autophagy | 1 | 2018 | 1326 | 0.090 |
Why?
|
RNA Splicing | 1 | 2015 | 918 | 0.090 |
Why?
|
Chemotaxis | 1 | 2013 | 598 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 473 | 0.080 |
Why?
|
Membrane Proteins | 4 | 2014 | 7856 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 477 | 0.080 |
Why?
|
Protein Structure, Secondary | 1 | 2012 | 1229 | 0.080 |
Why?
|
Hematopoietic Stem Cells | 4 | 2020 | 3396 | 0.080 |
Why?
|
Computational Biology | 2 | 2019 | 3518 | 0.080 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2011 | 344 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 2057 | 0.080 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2012 | 1693 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2021 | 1135 | 0.080 |
Why?
|
Regression Analysis | 2 | 2015 | 6343 | 0.080 |
Why?
|
Blotting, Western | 3 | 2011 | 5035 | 0.080 |
Why?
|
Ileum | 1 | 2011 | 557 | 0.080 |
Why?
|
Gamma Rays | 1 | 2009 | 318 | 0.080 |
Why?
|
E2F Transcription Factors | 1 | 2009 | 269 | 0.080 |
Why?
|
STAT3 Transcription Factor | 1 | 2012 | 871 | 0.080 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 4 | 2014 | 899 | 0.080 |
Why?
|
E2F1 Transcription Factor | 1 | 2008 | 178 | 0.080 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2009 | 218 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2735 | 0.070 |
Why?
|
Neural Stem Cells | 1 | 2015 | 888 | 0.070 |
Why?
|
Duodenum | 1 | 2011 | 490 | 0.070 |
Why?
|
Transcription Factors | 2 | 2023 | 12128 | 0.070 |
Why?
|
Ultraviolet Rays | 1 | 2012 | 1080 | 0.070 |
Why?
|
Microfluidics | 1 | 2013 | 653 | 0.070 |
Why?
|
Feedback, Physiological | 1 | 2009 | 476 | 0.070 |
Why?
|
Lung | 2 | 2024 | 10000 | 0.070 |
Why?
|
Proteins | 1 | 2022 | 6032 | 0.070 |
Why?
|
rac GTP-Binding Proteins | 1 | 2007 | 162 | 0.070 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2014 | 3613 | 0.070 |
Why?
|
Male | 17 | 2021 | 360804 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1626 | 0.070 |
Why?
|
Glutamate Dehydrogenase | 1 | 2006 | 50 | 0.070 |
Why?
|
Interleukin-10 | 2 | 2009 | 1175 | 0.070 |
Why?
|
RNA, Messenger | 2 | 2020 | 12795 | 0.070 |
Why?
|
Rats | 2 | 2020 | 23742 | 0.070 |
Why?
|
Interferon-gamma | 2 | 2012 | 3162 | 0.070 |
Why?
|
Cell Division | 2 | 2005 | 4465 | 0.070 |
Why?
|
Flow Cytometry | 3 | 2012 | 5869 | 0.070 |
Why?
|
Cell Separation | 1 | 2012 | 1720 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2014 | 2917 | 0.070 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2002 | 2510 | 0.070 |
Why?
|
Amino Acid Substitution | 3 | 2020 | 1738 | 0.070 |
Why?
|
Gelsolin | 1 | 2006 | 189 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5305 | 0.070 |
Why?
|
Toll-Like Receptor 4 | 1 | 2009 | 579 | 0.060 |
Why?
|
Cell Movement | 2 | 2020 | 5203 | 0.060 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4111 | 0.060 |
Why?
|
Gene Deletion | 2 | 2009 | 2665 | 0.060 |
Why?
|
Benzamides | 1 | 2011 | 1370 | 0.060 |
Why?
|
Protein Structure, Tertiary | 1 | 2012 | 3792 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2008 | 641 | 0.060 |
Why?
|
Glioma | 1 | 2020 | 3455 | 0.060 |
Why?
|
Intestinal Diseases | 1 | 2009 | 504 | 0.060 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2008 | 655 | 0.060 |
Why?
|
Transgenes | 2 | 2021 | 1010 | 0.060 |
Why?
|
Neoplasm Transplantation | 2 | 2021 | 2016 | 0.060 |
Why?
|
Animals, Congenic | 1 | 2004 | 27 | 0.060 |
Why?
|
Glutamine | 2 | 2024 | 577 | 0.060 |
Why?
|
Lipid Metabolism | 1 | 2013 | 1902 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2015 | 3492 | 0.060 |
Why?
|
Mitochondrial Proteins | 2 | 2024 | 976 | 0.060 |
Why?
|
Mitochondria | 2 | 2015 | 3624 | 0.060 |
Why?
|
Microglia | 1 | 2013 | 1361 | 0.060 |
Why?
|
DNA Damage | 2 | 2011 | 2446 | 0.060 |
Why?
|
Neoplasm Staging | 3 | 2014 | 11121 | 0.050 |
Why?
|
Prognosis | 4 | 2017 | 29625 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2018 | 2422 | 0.050 |
Why?
|
Microsatellite Instability | 3 | 2012 | 716 | 0.050 |
Why?
|
Transcription, Genetic | 3 | 2021 | 7594 | 0.050 |
Why?
|
DNA Methylation | 3 | 2014 | 4398 | 0.050 |
Why?
|
Macrophages | 1 | 2018 | 5769 | 0.050 |
Why?
|
Inflammation | 2 | 2019 | 10773 | 0.050 |
Why?
|
HEK293 Cells | 1 | 2012 | 4278 | 0.050 |
Why?
|
Genomics | 1 | 2019 | 5821 | 0.050 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 2827 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5315 | 0.050 |
Why?
|
Wnt Proteins | 3 | 2015 | 718 | 0.050 |
Why?
|
Radiation Injuries | 1 | 2009 | 1189 | 0.050 |
Why?
|
Chromosomes, Mammalian | 1 | 2002 | 147 | 0.050 |
Why?
|
Models, Genetic | 1 | 2012 | 3442 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2011 | 2448 | 0.050 |
Why?
|
Embryonic Development | 1 | 2007 | 721 | 0.050 |
Why?
|
Neuropeptides | 1 | 2007 | 944 | 0.050 |
Why?
|
GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2021 | 43 | 0.050 |
Why?
|
Long Interspersed Nucleotide Elements | 2 | 2014 | 330 | 0.050 |
Why?
|
Dendritic Cells | 1 | 2012 | 2747 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2012 | 3702 | 0.050 |
Why?
|
Mice, Mutant Strains | 3 | 2011 | 1749 | 0.050 |
Why?
|
Female | 13 | 2021 | 392644 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2021 | 6216 | 0.040 |
Why?
|
Karyotyping | 1 | 2002 | 1171 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2002 | 11076 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 2 | 2019 | 1188 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2006 | 1341 | 0.040 |
Why?
|
Phosphopeptides | 1 | 2021 | 240 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2002 | 852 | 0.040 |
Why?
|
Palmitic Acid | 1 | 2020 | 149 | 0.040 |
Why?
|
Hydrolases | 1 | 2020 | 147 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2005 | 1136 | 0.040 |
Why?
|
Appendiceal Neoplasms | 1 | 2021 | 155 | 0.040 |
Why?
|
RNA, Small Interfering | 3 | 2015 | 3429 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4414 | 0.040 |
Why?
|
Insulin-Secreting Cells | 1 | 2006 | 901 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10766 | 0.040 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2021 | 507 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2009 | 3080 | 0.040 |
Why?
|
Brain | 2 | 2015 | 27112 | 0.040 |
Why?
|
Adoptive Transfer | 1 | 2021 | 819 | 0.040 |
Why?
|
Hydrolysis | 1 | 2019 | 664 | 0.040 |
Why?
|
Gene Dosage | 1 | 2002 | 1217 | 0.040 |
Why?
|
Aspartic Acid | 1 | 2020 | 576 | 0.040 |
Why?
|
DNA Primers | 1 | 2002 | 2819 | 0.040 |
Why?
|
Organoids | 1 | 2024 | 740 | 0.040 |
Why?
|
NADH Dehydrogenase | 1 | 2017 | 47 | 0.040 |
Why?
|
Protein Stability | 1 | 2019 | 578 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2007 | 3208 | 0.040 |
Why?
|
Heterozygote | 1 | 2004 | 2787 | 0.040 |
Why?
|
Survival Analysis | 3 | 2016 | 10090 | 0.040 |
Why?
|
Liver | 1 | 2013 | 7529 | 0.040 |
Why?
|
Homozygote | 1 | 2002 | 1776 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2007 | 2803 | 0.040 |
Why?
|
Cell Line | 4 | 2017 | 15601 | 0.040 |
Why?
|
Hydrazones | 1 | 2017 | 103 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2021 | 868 | 0.030 |
Why?
|
Glycine | 1 | 2020 | 663 | 0.030 |
Why?
|
Mice, SCID | 1 | 2021 | 2626 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2005 | 2416 | 0.030 |
Why?
|
Minocycline | 1 | 2017 | 169 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2004 | 1858 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2007 | 3448 | 0.030 |
Why?
|
Molecular Structure | 1 | 2020 | 1880 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2015 | 58976 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17904 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2007 | 3612 | 0.030 |
Why?
|
Time Factors | 3 | 2013 | 39967 | 0.030 |
Why?
|
Actins | 1 | 2022 | 2050 | 0.030 |
Why?
|
Aged | 7 | 2016 | 169289 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2000 | 1342 | 0.030 |
Why?
|
Melanoma | 1 | 2012 | 5709 | 0.030 |
Why?
|
Carrier Proteins | 2 | 2004 | 4936 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2012 | 6132 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11742 | 0.030 |
Why?
|
Algorithms | 1 | 2013 | 14031 | 0.030 |
Why?
|
Myeloid Progenitor Cells | 1 | 2013 | 113 | 0.030 |
Why?
|
Monophenol Monooxygenase | 1 | 2012 | 72 | 0.030 |
Why?
|
Receptor, Melanocortin, Type 1 | 1 | 2012 | 74 | 0.030 |
Why?
|
Peroxidases | 1 | 2012 | 134 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6484 | 0.030 |
Why?
|
Regeneration | 1 | 2021 | 1511 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 802 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4575 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 2004 | 5796 | 0.020 |
Why?
|
Triazoles | 1 | 2017 | 903 | 0.020 |
Why?
|
Drosophila | 1 | 2019 | 1495 | 0.020 |
Why?
|
Middle Aged | 6 | 2015 | 220895 | 0.020 |
Why?
|
Base Sequence | 1 | 2002 | 12441 | 0.020 |
Why?
|
DNA-Cytosine Methylases | 1 | 2010 | 17 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 371 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2011 | 659 | 0.020 |
Why?
|
Melanins | 1 | 2012 | 290 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2011 | 749 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 867 | 0.020 |
Why?
|
Prospective Studies | 2 | 2012 | 54425 | 0.020 |
Why?
|
Lymphopoiesis | 1 | 2010 | 133 | 0.020 |
Why?
|
Spermatozoa | 1 | 2014 | 630 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9606 | 0.020 |
Why?
|
Myelopoiesis | 1 | 2010 | 134 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2011 | 491 | 0.020 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2009 | 71 | 0.020 |
Why?
|
Gene Expression | 2 | 2014 | 7581 | 0.020 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2009 | 71 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2014 | 877 | 0.020 |
Why?
|
Peptides | 1 | 2021 | 4358 | 0.020 |
Why?
|
Pyridines | 1 | 2021 | 2875 | 0.020 |
Why?
|
Rectal Prolapse | 1 | 2009 | 33 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3602 | 0.020 |
Why?
|
Fluorouracil | 1 | 2014 | 1641 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 8 | 1 | 2008 | 48 | 0.020 |
Why?
|
Autocrine Communication | 1 | 2009 | 169 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2011 | 471 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2014 | 12463 | 0.020 |
Why?
|
bcl-2-Associated X Protein | 1 | 2009 | 282 | 0.020 |
Why?
|
Zebrafish | 1 | 2020 | 3007 | 0.020 |
Why?
|
Codon, Nonsense | 1 | 2009 | 285 | 0.020 |
Why?
|
TCF Transcription Factors | 1 | 2008 | 138 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2015 | 1403 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9351 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3639 | 0.020 |
Why?
|
RecQ Helicases | 1 | 2007 | 53 | 0.020 |
Why?
|
DNA Ligases | 1 | 2007 | 82 | 0.020 |
Why?
|
Pathology, Molecular | 1 | 2010 | 328 | 0.020 |
Why?
|
Genes, myc | 1 | 2008 | 390 | 0.020 |
Why?
|
Adenosine Diphosphate Ribose | 1 | 2006 | 69 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2015 | 2385 | 0.020 |
Why?
|
Erythropoiesis | 1 | 2010 | 683 | 0.020 |
Why?
|
Radiation, Ionizing | 1 | 2007 | 251 | 0.020 |
Why?
|
Mesoderm | 1 | 2009 | 674 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2008 | 411 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2009 | 878 | 0.020 |
Why?
|
RNA Interference | 1 | 2015 | 2831 | 0.020 |
Why?
|
Multigene Family | 1 | 2009 | 1076 | 0.020 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2007 | 242 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 306 | 0.020 |
Why?
|
Caco-2 Cells | 1 | 2006 | 364 | 0.020 |
Why?
|
Protein Transport | 1 | 2011 | 1967 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6075 | 0.020 |
Why?
|
Chemokines | 1 | 2009 | 960 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2009 | 2469 | 0.020 |
Why?
|
Sirtuin 1 | 1 | 2006 | 246 | 0.020 |
Why?
|
Myeloproliferative Disorders | 1 | 2010 | 613 | 0.010 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2012 | 1250 | 0.010 |
Why?
|
Cell Death | 1 | 2009 | 1678 | 0.010 |
Why?
|
Genetic Markers | 1 | 2010 | 2601 | 0.010 |
Why?
|
Th1 Cells | 1 | 2009 | 1036 | 0.010 |
Why?
|
Caloric Restriction | 1 | 2006 | 299 | 0.010 |
Why?
|
Interleukin-17 | 1 | 2009 | 912 | 0.010 |
Why?
|
Spleen | 1 | 2009 | 2295 | 0.010 |
Why?
|
Adenosine Triphosphatases | 1 | 2007 | 835 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2015 | 13446 | 0.010 |
Why?
|
Sulfonamides | 1 | 2012 | 1978 | 0.010 |
Why?
|
NAD | 1 | 2006 | 614 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3810 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 17635 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2009 | 1616 | 0.010 |
Why?
|
DNA Helicases | 1 | 2007 | 851 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2009 | 1958 | 0.010 |
Why?
|
Base Pair Mismatch | 1 | 2000 | 92 | 0.010 |
Why?
|
Amino Acids | 1 | 2006 | 1718 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12725 | 0.010 |
Why?
|
Cohort Studies | 2 | 2014 | 41487 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29874 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2010 | 4740 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2007 | 3595 | 0.010 |
Why?
|
Down-Regulation | 1 | 2006 | 2919 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2010 | 3575 | 0.010 |
Why?
|
Transfection | 1 | 2006 | 5774 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3778 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5789 | 0.010 |
Why?
|
Genetic Testing | 1 | 2010 | 3537 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2014 | 80636 | 0.010 |
Why?
|
Glucose | 1 | 2006 | 4346 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39106 | 0.010 |
Why?
|
Insulin | 1 | 2006 | 6596 | 0.010 |
Why?
|
Adult | 2 | 2014 | 221177 | 0.010 |
Why?
|
Young Adult | 1 | 2014 | 59243 | 0.000 |
Why?
|
Risk Factors | 1 | 2014 | 74206 | 0.000 |
Why?
|
Adolescent | 1 | 2014 | 88319 | 0.000 |
Why?
|